- Home
- PLMK vs KRRO Comparison
PLMK vs KRRO Comparison
Compare PLMK & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLMK
- KRRO
- Stock Information
- Founded
- PLMK 2024
- KRRO 2014
- Country
- PLMK United States
- KRRO United States
- Employees
- PLMK N/A
- KRRO N/A
- Industry
- PLMK
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- PLMK
- KRRO Health Care
- Exchange
- PLMK NYSE
- KRRO Nasdaq
- Market Cap
- PLMK 241.7M
- KRRO 281.2M
- IPO Year
- PLMK 2025
- KRRO 2019
- Fundamental
- Price
- PLMK $9.99
- KRRO $26.29
- Analyst Decision
- PLMK
- KRRO Strong Buy
- Analyst Count
- PLMK 0
- KRRO 7
- Target Price
- PLMK N/A
- KRRO $133.83
- AVG Volume (30 Days)
- PLMK 76.6K
- KRRO 59.9K
- Earning Date
- PLMK 01-01-0001
- KRRO 03-25-2025
- Dividend Yield
- PLMK N/A
- KRRO N/A
- EPS Growth
- PLMK N/A
- KRRO N/A
- EPS
- PLMK N/A
- KRRO N/A
- Revenue
- PLMK N/A
- KRRO N/A
- Revenue This Year
- PLMK N/A
- KRRO N/A
- Revenue Next Year
- PLMK N/A
- KRRO N/A
- P/E Ratio
- PLMK N/A
- KRRO N/A
- Revenue Growth
- PLMK N/A
- KRRO N/A
- 52 Week Low
- PLMK $9.94
- KRRO $26.23
- 52 Week High
- PLMK $9.99
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- PLMK N/A
- KRRO 29.17
- Support Level
- PLMK N/A
- KRRO $28.90
- Resistance Level
- PLMK N/A
- KRRO $40.68
- Average True Range (ATR)
- PLMK 0.00
- KRRO 2.26
- MACD
- PLMK 0.00
- KRRO -0.36
- Stochastic Oscillator
- PLMK 0.00
- KRRO 0.42
About PLMK PLUM ACQUISITION CORP IV
Plum Acquisition Corp IV is a blank check company.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.